| abstract |
FIELD: medicine, in particular, pharmaceutics and pharmacotherapy, applicable for production of preparation for treatment of endogenic bronchial asthma and for treatment of patients suffering from this disease. SUBSTANCE: the preparation contains cytostatic, as cytostatic it uses Melfalan dispersed in an effective dose in the gas phase up to formation of aerosol, the effective dose of Melfalan makes up 0.01 to 0.5 mg, as well as the method for treatment of patients suffering from endogenic bronchial asthma, including introduction of cytostatic - Melfalan in a daily dose of 0.01 to 0.5 mg that is introduced to patients by means of inhalation. EFFECT: improved clinical results against the background of absence of by-effect of medicaments. 6 cl |